Kairos Pharma Ltd.
Organization details
- Legal name
- Kairos Pharma Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- LOS Angeles
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KAPA
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001962011
- EIN
- 46-2993314
Board of directors
-
Hansoo Michael Keyoung · DirectorSince 2024
-
Hyun W. Bae · DirectorSince 2024
-
John S. Yu · Director · CEO and ChairmanSince 2024
-
Rahul Singhvi · DirectorSince 2024
-
Rosemary Mazanet · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.8%
-
99.8%
-
99.8%
Board connections
1 of this board's directors also sit on 1 other board.
- via Rahul Singhvi
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2025 | Bhowmick Neil Officer (Chief Scientific Officer) | Grant or award | +171,756 | — | — |
| Oct 8, 2025 | Murali Ramachandran Officer (VP of Research and Development) | Grant or award | +152,672 | — | — |
| Oct 8, 2025 | Rahul Singhvi Director | Grant or award | +19,084 | — | — |
| Oct 8, 2025 | Samuelson Doug Officer (Chief Financial Officer) | Grant or award | +152,672 | — | — |
| Oct 8, 2025 | John S. Yu Director, Officer (CEO and Chairman), 10% owner | Grant or award | +190,840 | — | — |
| Oct 8, 2025 | Hyun W. Bae Director | Grant or award | +19,084 | — | — |
| Oct 8, 2025 | Hansoo Michael Keyoung Director | Grant or award | +19,084 | — | — |
| Sep 16, 2025 | Hyun W. Bae Director | Grant or award | +10,000 | — | — |
| Sep 16, 2025 | Hansoo Michael Keyoung Director | Grant or award | +10,000 | — | — |
| Jan 1, 2025 | Murali Ramachandran Officer (VP of Research and Development) | Grant or award | +14,000 | — | — |
| Jan 1, 2025 | John S. Yu Director, Officer (CEO and Chairman), 10% owner | Grant or award | +14,000 | — | — |
| Jan 1, 2025 | Bhowmick Neil Officer (Chief Scientific Officer) | Grant or award | +14,000 | — | — |
| Nov 25, 2024 | Murali Ramachandran Officer (VP of Research and Development) | Open-market purchase | +200 | $1.59 | $318 |
| Nov 22, 2024 | Samuelson Doug Officer (Chief Financial Officer) | Open-market purchase | +2,500 | $1.50 | $3,750 |
| Nov 20, 2024 | John S. Yu Director, Officer (CEO and Chairman), 10% owner | Open-market purchase | +4,000 | $1.44 | $5,760 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Kairos Pharma Ltd.
Who is the CEO of Kairos Pharma Ltd.?
John S. Yu has been Kairos Pharma Ltd.'s CEO and Chairman since September 2024.
How many directors are on Kairos Pharma Ltd.'s board?
Kairos Pharma Ltd.'s board has 5 directors: Hansoo Michael Keyoung, Hyun W. Bae, John S. Yu, Rahul Singhvi and Rosemary Mazanet.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="kairos-pharma-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.